Welcome to our website

In researches reviewing growth rate, the security profile in these pediatric patients followed the safety and security profile previously described for Singulair.

The safety profile of Singulair, when administered as a single dosage for prevention of EIB in pediatric individuals 6 years of age and older, followed the security profile formerly explained for Singulair.

Never ever take a double amount as an alternative.

Although Singulair is effective in boosting air passage function in asthmatics with documented aspirin sensitivity, it has not been revealed to truncate bronchoconstrictor reaction to aspirin and various other non-steroidal anti-inflammatory drugs in aspirin-sensitive asthmatic people [ see Clinical Studies (14.